← FDA Drug Approvals (Drugs@FDA)
TRICHLORMETHIAZIDE W/ RESERPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1983-04-13
Drug application
- FDA Application #
ANDA085248- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRICHLORMETHIAZIDE W/ RESERPINE
- Generic name
- Reserpine
- Active ingredients
- RESERPINE; TRICHLORMETHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- WATSON LABS
- First approval
- 1983-04-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown